Isomangiferin promotes the migration and osteogenic differentiation of rat bone marrow mesenchymal stem cells
Authors:
Open Access
- 1 January 2024
- journal article
- research article
- Published by Walter de Gruyter GmbH in Open Life Sciences
- Vol. 19 (1) , 20220884
Abstract
Delayed or failed bone healing is a significant clinical challenge worldwide. Bone marrow mesenchymal stem cells (BMSCs) offer a promising approach for improving fracture healing. Isomangiferin, a xanthone C-glucoside, is known for its pharmacological activities, but its role in fracture healing remains unclear. In this study, we investigated the effects of isomangiferin on BMSCs under oxidative stress conditions induced by hydrogen peroxide (H2O2). Our results showed that isomangiferin promotes osteogenic differentiation and migration of H2O2-treated BMSCs, reduces apoptosis and reactive oxygen species production, and activates the AMP-activated protein kinase/acetyl-CoA carboxylase (AMPK/ACC) pathway. These findings suggest that isomangiferin may be a potential therapeutic agent for enhancing bone healing by modulating BMSC function.Keywords
This publication has 20 references indexed in Scilit:
- Outcomes of Distal Radius Fractures in Solid Organ Transplant RecipientsThe Journal of Hand Surgery, 2023
- Biomechanical evaluation of CAD/CAM magnesium miniplates as a fixation strategy for the treatment of segmental mandibular reconstruction with a fibula free flapComputers in Biology and Medicine, 2023
- Circ_C4orf36 Promotes the Proliferation and Osteogenic Differentiation of BMSCs by Regulating VEGFABiochemical Genetics, 2022
- Bioinspired drug-delivery system emulating the natural bone healing cascade for diabetic periodontal bone regenerationBioactive Materials, 2022
- Fasudil enhanced differentiation of BMSCs in vivo and vitro, involvement of P38 signaling pathwayChemico-Biological Interactions, 2020
- Mitochondrial E3 ubiquitin ligase 1 promotes brain injury by disturbing mitochondrial dynamics in a rat model of ischemic strokeEuropean Journal of Pharmacology, 2019
- RETRACTED ARTICLE: miR-381 modulates human bone mesenchymal stromal cells (BMSCs) osteogenesis via suppressing Wnt signaling pathway during atrophic nonunion developmentCell Death & Disease, 2019
- Development and validation of a liquid chromatography with tandem mass spectrometry method for the determination of isomangiferin in rat plasma with application to a preclinical pharmacokinetic studyJournal of Separation Science, 2016
- The anti-diabetic drug metformin does not affect bone mass in vivo or fracture healingOsteoporosis International, 2013
- Differential gene expression analysis in fracture callus of patients with regular and failed bone healingInjury, 2012